Finance

Lists
318010:KOSDAQ
Pharmsville Co Ltd
₩3,690.00
0.00%
(0.00) 1D
Jul 24, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 318010...
Open
₩3,690
High
₩3,690
Low
₩3,440
Mkt. cap
29.26B
Avg. vol.
10.99K
Volume
21.86K
Dividend
5.42%
Quarterly dividend
₩50
Ex-dividend date
Dec 29, 2025
P/E ratio
9.54
52-wk high
₩6,010
52-wk low
₩3,135
EPS
₩387
Shares outstanding
7.93M
No. of employees
21
Open
₩3,690
High
₩3,690
Low
₩3,440
Mkt. cap
29.26B
Avg. vol.
10.99K
Volume
21.86K
Dividend
5.42%
Quarterly dividend
₩50
Ex-dividend date
Dec 29, 2025
P/E ratio
9.54
52-wk high
₩6,010
52-wk low
₩3,135
EPS
₩387
Shares outstanding
7.93M
No. of employees
21
News stories
From sources across the web
About Pharmsville Co Ltd
CEO-
Employees21
Founded2000
Headquarters-
SectorPersonal care products
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.34B
3.37B
2.96B
2.49B
Cost of goods sold
1.17B
1.17B
1.23B
861.22M
Cost of revenue
1.17B
1.17B
1.23B
861.22M
Research and development expenses
298.28M
515.65M
569.20M
290.51M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.74B
1.72B
1.48B
1.36B
Operating expense
2.08B
2.32B
2.09B
1.68B
Total operating expenses
3.25B
3.49B
3.32B
2.55B
Operating income
88.91M
-120.36M
-351.80M
-59.69M
Other non operating income
156.08M
290.97M
542.62M
210.39M
EBT including unusual items
1.29B
833.26M
1.21B
1.46B
EBT excluding unusual items
326.77M
201.58M
216.66M
190.27M
Income tax expense
184.09M
332.90M
375.54M
248.72M
Effective tax rate
14.28%
39.95%
31.13%
17.00%
Other operating expenses
15.95M
59.67M
14.15M
11.05M
Net income
1.10B
493.65M
824.26M
1.20B
Net profit margin
33.10%
14.65%
27.81%
48.47%
Earnings per share
-
-
-
-
Interest and investment income
74.69M
22.46M
30.32M
14.37M
Interest expense
-250.00K
-213.00K
-200.00K
-186.00K
Net interest expenses
74.44M
22.25M
30.12M
14.18M
Depreciation and amortization charges
24.41M
23.48M
18.57M
16.20M
EBITDA
372.93M
45.87M
-212.60M
63.48M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more